Ontario and Quebec have announced that they are now seeing a seventh wave of COVID-19 infections, although case numbers are uncertain due to a lack of reporting. Health Canada reports 21,317 new cases for the week ending July 8, but acknowledges that this is an underestimate (https://health-infobase.canada.ca/src/data/covidLive/Epidemiological-summary-of-COVID-19-cases-in-Canada-Canada.ca.pdf). The Northwest Territories and Nunavut no longer publish COVID case numbers while Saskatchewan posts case numbers only once a month. Read More
COVID-19
Key changes in Canadian MS care during the pandemic
July 7, 2022Pandemic prescribing – what changed?
July 6, 2022Use of disease-modifying therapies for MS changed substantially during the pandemic among clinicians and patients, according to two studies presented at the European Academy of Neurology (EAN) 2022 annual meeting. Read More
EAN 2022 HIGHLIGHTS – THURSDAY, JUNE 30 EDITION
June 30, 2022Selected highlights from the European Academy of Neurology annual meeting, Vienna, Austria, June 25-28, 2022.
June 29 Edition
June 28 Edition
NfL, GFAP elevated post-COVID
Long-term data for anti-CD20 agents
Improved cognitive processing speed with ofatumumab
Cognitive impairment may predict physical disability
B cell kinetics during pregnancy
Clinical tip of the day
Read More
EAN 2022 HIGHLIGHTS – TUESDAY, JUNE 28 EDITION
June 28, 2022Selected highlights from the European Academy of Neurology annual meeting, Vienna, Austria, June 25-28, 2022.
June 30 Edition
June 29 Edition
Relapses uncommon after COVID vaccination
The aging MS patient
Ocrelizumab EID
Natalizumab EID
Clinical tip of the day
Read More